Page 22 - Read Online
P. 22

Page 94                Oquendo et al. J Transl Genet Genom 2021;5:89-111  https://dx.doi.org/10.20517/jtgg.2021.04

               Recurring translocations are much less frequent than in other low-grade lymphomas such as MCL, FL and
               mucosa associated lymphoid tissue lymphoma, and usually involve the IGHV locus. These include
               t(14;19)(q32;q13), t(6;14)(p21;q32), t(9;14)(p13;q32), t(1;14)(q21;q32) which target the genes BCL3, CCND3,
               PAX5 and BCL9/MUC1, respectively. Translocations of 7q21, have been documented in some cases,
               predominantly with the immunoglobulin kappa locus resulting in upregulation of CDK6 .
                                                                                         [47]

               MUTATIONS IN KEY GENES AND PATHWAYS
               Whole genome/exome sequencing (WGS/WES) has been employed to scan the entire cancer genome at
               base-pair resolution and identify somatically acquired gene mutations across a broad spectrum of mature B-
               cell tumours [48-52] . The analysis of large patient cohorts, often conducted as part of large international
               sequencing consortia, has provided a wealth of genomic information on these neoplasms, identifying a
               plethora of germ-line SNPs associated with disease-risk, panels of genes targeted by somatic mutations and
               a number of acquired mutational mechanisms. Unlike more prevalent mature B-cell malignancies, SMZL is
               currently precluded from these international sequencing projects, the result being an incomplete catalogue
               of tumour associated genomic lesions and mutational processes, drawn from a paucity of published
                                                                                          [53]
               genomic data. Only six genome-wide studies have been conducted on only 35 patients . The only study
               employing WGS was performed by Kiel et al.  but was limited to six cases without matched germline
                                                       [54]
               DNA. Five WES studies have been carried out on discovery cases, often with subsequent targeted re-
               sequencing of relevant genes in additional samples. To date, none of these studies have reported mutational
                                                                       [55]
               signatures nor mechanisms, such as kataegis and chromothripsis . Even the somatic mutational burden
               remains disputed, with a range of somatic mutations per patients of between 9 and 82 (mean 25) [23,56,57] . This
               limited agreement is likely due to the low patient numbers, and experimental and computational differences
               in WGS/WES processing, but could also allude to disease heterogeneity and statistical power insufficient to
               catalogue the complete mutational landscape of the disease [23,53] . Targeted re-sequencing approaches have
               helped elucidate recurrently mutated genes, but these studies have often included only small numbers of
               matched germ-line material for analysis. Whilst we currently have only a limited picture of the somatic
               landscape of SMZL, several recurrently mutated genes have been identified, which preferentially target
               physiologically important cellular processes, such as MZ B-cell maturation and migration, and cell cycle
               control [Figure 2]. A number of genomic studies, with limited functional validation, all agree that the most
               important recurrently mutated genes are KLF2, NOTCH2 and TP53.


               KLF2 mutations are present in up to 40% of SMZL cases
               KLF2 is the most frequently mutated gene in SMZL (20%-40% of cases) [24,33,58,59] . The gene belongs to the
               family of Kruppel-like transcription factors, a subfamily of the zinc-finger class of DNA binding
               transcriptional regulators . KLF2 directly binds to promoters regulating the expression of genes involved
                                     [60]
               in cell homing, NF-κB signalling and cell cycle control [23,61] . In murine systems, loss of KLF2 drives the
               germinal cells to a MZ-like phenotype and preclusion of migration to the splenic MZ [62-64] , thereby
               preventing germinal centre B-cell responses to antigens in the MZ. Nuclear localization of the KLF2 protein
               and consequent DNA binding require three C-terminal highly conserved zinc finger domains and two
               nuclear localization sequences, respectively. Gene mutations can be missense substitutions or truncating
               events [Figure 3], where the latter often results in the removal of the nuclear localization sequences [23,24,33,58] .
               Missense substitutions result in amino acid changes within the nuclear localization sequences of KLF2 or
               within highly conserved regions of the first zinc finger domain. These KLF2 mutants render the protein
               unable to elicit its transcriptional activity by displacement from the nucleus thereby preventing the ability of
               KLF2 to supress NF-κB induction by upstream signalling pathways [23,33] . The p.Q24X (stopgain) variant is a
               hotspot mutation [23,24,33,59] . Although no functional evidence on this specific variant is available, it is very
               likely that due to its position on the first exon it would result in a truncated and non-functional protein.
               Furthermore, this variant has a scaled Combined Annotation Dependent depletion  score of 36 indicating
                                                                                     [65]
   17   18   19   20   21   22   23   24   25   26   27